Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade
Marshall, A.J.; Barritt, D.W.; Harry, J.D.
Postgraduate Medical Journal 53(Suppl): 168-172
1977
ISSN/ISBN: 0032-5473 PMID: 337271 Document Number: 119115
Document emailed within 1 workday
Related Documents
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40Dany, F.; Lagrée, S.; Clémenty, J.; Prague, Y.; Salamon, R.; Dallocchio, M. 1979: Left ventricular function in hypertension. Echographic evaluation before and after beta blockade (atenolol) Archives des Maladies du Coeur et des Vaisseaux 72(6): 662-668
Lindroos, M.; Lehtonen, A. 1984: Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration International Journal of Clinical Pharmacology Therapy and Toxicology 22(12): 643-645
Takahashi, H.; Fukuyama, M.; Yoneda, S.; Okabayashi, H.; Yoshimura, M. 1989: Comparison of nisoldipine and atenolol in the treatment of essential hypertension Arzneimittel-Forschung 39(3): 379-382
Brecht, H.M.; Vlachoyannis, J.; Musil, H.A.; Ernst, W.; Weismüller, G.; Schoeppe, W. 1975: Changes in plasma catecholamine concentration and cyclic AMP secretion following beta-blockade in essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1035-1038
Lang, R. 1980: Balance of noradrenaline and sodium during chronic beta-receptor blockade in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 67-75
Rathaus, M.; Magen, A.; Rath-Wolfson, L.; Shapira, J.; Bernheim, J. 1983: Effect of atenolol treatment on urinary prostaglandins E2 and F2 alpha in essential hypertension Israel Journal of Medical Sciences 19(12): 1072-1074
Shiotani, M.; Arita, M.; Nakatsu, C.; Nakamura, N.; Ohshika, H.; Nakamura, Y.; Fujiwara, S.; Ueno, Y.; Nishio, I.; Masuyama, Y. 1990: Effects of calcium antagonists or beta-blockade on left ventricular diastolic function in essential hypertension Journal of Cardiology 20(1): 135-145
De Leeuw, P.W.; Birkenhäger, W.H. 1983: Alpha-adrenergic blockade in the treatment of essential hypertension Netherlands Journal of Medicine 26(9): 274-282
Orabona, M.L.; Maiorano, G.; Loiacono, N. 1975: Spironolactone in essential hypertension. Controlled study on the dose-response relationship Minerva Cardioangiologica 23(12): 866-870
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Balansard, P.; Chabrillat, Y.; Paulin, R.; Libes, M.; Gérard, R. 1977: Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension Acta Cardiologica 32(4): 229-243
Teufel, W.; Glocke, M. 1981: Advantages of hypertension therapy with the once daily administration of a combination of beta-blocker and diuretic. Experiences with the self-measurement of blood pressure Therapie der Gegenwart 120(5): 470-485
Longhini, C.; Ansani, L.; Musacci, G.F.; Vaccari, M.; Fraccaroli, G.P.; Mele, D.; Aggio, S.; Baracca, E. 1989: Evaluation of the cardiac and peripheral vascular effects of the single-dose administration of enalapril and captopril in essential arterial hypertension Cardiologia 34(9): 813
Prichard, B.N.; Saul, P.A. 1990: Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension Journal of Cardiovascular Pharmacology 16(Suppl 5): S81-S85
Fowler, M.B.; Brudenell, M.; Jackson, G.; Holt, D.W. 1984: Essential hypertension and pregnancy: successful outcome with atenolol British Journal of Clinical Practice 38(2): 73-74
Ciaramelli, F. 1978: Single daily dose of pindolol in the treatment of arterial hypertension La Nouvelle Presse Medicale 7(31): 2761-2764
Bühler, F.R.; Lütold, B.E. 1976: Beta adrenergic receptor blockade as a basis for the treatment of hypertension Therapeutische Umschau. Revue Therapeutique 33(5): 336-346
Watson, R.R.; Moriguchi, S.; Jackson, J.C.; Werner, L.; Wilmore, J.H.; Freund, B.J. 1986: Modification of cellular immune functions in humans by endurance exercise training during beta-adrenergic blockade with atenolol or propranolol Medicine and Science in Sports and Exercise 18(1): 95-100
Silke, B.; Guy, S.; Humphreys, J.E. 1992: Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension Journal of Human Hypertension 6(3): 221-225